Maddie is a former writer and editor for Forbes Advisor Health. She is based in Durham, North Carolina. Prior to joining Forbes Health, Maddie was a personal finance editor at Credible where she ...
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results